Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Composite International Diagnositc Interview - Substance Abuse Module

Abbreviation
CIDI-SAM
Description

The SAM is an expanded and more detailed version of the substance use section of the CIDI. The four diagnostic sections cover tobacco, alcohol, drugs, and caffeine. The drug section include amphetamines and other stimulants, cannabinoids, cocaine, PCP and other hallucinogens, inhalants, heroin and other opiates, barbiturates and other sedatives and tranquilizers. The SAM includes questions about onset and recency of specific symptoms, as well as the specific withdrawal symptoms and physical, social, and psychological consequences for each category of substances used. Also included are the quantity and frequency of both the heaviest and past 12 month use, and ages associated with use and remission. The SAM also assesses the respondent’s impairment and treatment seeking.

Category
Substance Use
Subcategory
Tobacco
Alcohol
Drugs
Studies Using This Assessment